Philippines eyes Avigan clinical trials in 3 hospitals.
The Philippines has identified 3 hospitals to possibly conduct clinical trials of anti-flu drug Avigan as a treatment against COVID-19.
In a virtual meeting, Health Undersecretary Maria Rosario Vergeire said, Sta. Ana Hospital, Dr. Jose N. Rodriguez Memorial Hospital and Quirino Memorial Medical Center in Metro Manila have been designated as possible clinical sites for the Japanese-made medication.
“As a protocol, this trial is undergoing an ethics review. It will then be registered for a clinical trial to the Food and Drug Administration (FDA),” she said.
The FDA regulates the conduct of clinical trials in the country. Japan had promised to provide supplies of Avigan to the Philippines and 40 other countries for clinical studies.
The Philippines had also joined the World Health Organization’s solidarity trial, which tests drugs believed to help treat COVID-19 patients. Some 220 Filipinos are currently enrolled in the clinical trial.
The solidarity trial involves the participation of more than 100 countries who want to help test off-label drugs believed to have a positive effect on coronavirus patients. These are (1) Remdesivir, (2) Lopinavir and Ritonavir combined, (3) Lopinavir and Ritonavir plus Interferon Beta, and (4) Chloroquine.